Skip to main content

Table 2 G8 Screening Tool

From: The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

 

Items

Possible Answers

A

Has food intake declined over the past 3 months due to loss of appetite, digestive problems, chewing or swallowing difficulties?

0: severe reduction in food intake

1: moderate reduction in food intake

2: normal food intake

B

Weight loss during the last 3 months?

0: weight loss > 3 kg

1: does not know

2: weight loss between 1 and 3 kg

3: no weight loss

C

Mobility

0: bed or chair bound

1: able to get out of bed/chair but does not go out

2: goes out

D

Neuropsychological problems

0: severe dementia or depression

1: mild dementia or depression

2: no psychological problems

F

Body Mass Index (weight in kg/height in m2)

0: BMI less than 19

1: BMI 19 to less than 21

2: BMI 21 to less than 23

3: BMI 23 or greater

G

Takes more than 3 medications per day

0: yes

1: no

H

In comparison with other people of the same age, how does the patient consider his/her health status?

0: not as good

0,5: does not know

1: as good

2: better

I

Age

0: > 85

1: 80–85

2: < 80